Lovastatin lowers the risk of breast cancer: a population-based study using logistic regression with a random effects model.

Springerplus · 2016 · PMC5101241 · PMID 27872797

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

did not reach statistical significancep < 0.077so close (0.05 < p ≤ 0.1)

Simvastatin, pravastatin, fluvastatin, and atorvastatin did not exhibit a statistically significant protective effect against breast cancer, although atorvastatin showed a protective tendency against breast cancer which did not reach statistical significance (adjusted OR 0.887; 95% CI 0.776–1.013; p < 0.077).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.